6/ The new LP.8.1-adapted vaccine markedly increases levels of antibodies that neutralize XFG, while this effect is substantially less pronounced for BA.3.2.

3/ When examining plasma from individuals who received the JN.1-adapted vaccine, we observe similar levels of antibody evasion for XFG and BA.3.2. This is consistent with earlier studies.

1️⃣ Georg Behrens, Markus Hoffmann & team examined antibody responses induced by the novel LP.8.1-adapted mRNA vaccine.

Years without meeting in Germany despite many joint projects - but in Paris, we bump into each other instantly. Merci, coincidence! 🇫🇷😀

Lu Zhang reporting on the SARS-CoV-2 variant BA.3.2 at #EMVZ, St Raphael, France. Great job, Lu!

Been traveling with little internet & almost missed it: BA.3.2 shows high frequency in infections but low in wastewater. Start of a JN.1-like spread, or just the last blip of a fading variant?

#BA32

3/5
These antibodies blocked infection by single cycle reporter particles carrying H5 + N1 proteins (see figure 👇).

Congrats, Lu, on the PhD prize of the Bernhard and Ingrid Fleckenstein Foundation! Well deserved!

Antibody evasion of mutant E484D.